BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23307033)

  • 21. Promotion of the self-renewal capacity of human acute leukemia cells by Wnt3A.
    Kawaguchi-Ihara N; Murohashi I; Nara N; Tohda S
    Anticancer Res; 2008; 28(5A):2701-4. PubMed ID: 19035298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways.
    Jiang H; Tang J; Qiu L; Zhang Z; Shi S; Xue L; Kui L; Huang T; Nan W; Zhou B; Zhao C; Yu M; Sun Q
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.
    Naudin C; Hattabi A; Michelet F; Miri-Nezhad A; Benyoucef A; Pflumio F; Guillonneau F; Fichelson S; Vigon I; Dusanter-Fourt I; Lauret E
    Blood; 2017 May; 129(18):2493-2506. PubMed ID: 28232582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia.
    Salik B; Yi H; Hassan N; Santiappillai N; Vick B; Connerty P; Duly A; Trahair T; Woo AJ; Beck D; Liu T; Spiekermann K; Jeremias I; Wang J; Kavallaris M; Haber M; Norris MD; Liebermann DA; D'Andrea RJ; Murriel C; Wang JY
    Cancer Cell; 2020 Aug; 38(2):263-278.e6. PubMed ID: 32559496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ph+/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells.
    Wang L; O'Leary H; Fortney J; Gibson LF
    Blood; 2007 Nov; 110(9):3334-44. PubMed ID: 17638851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Env gene expression of human endogenous retrovirus-k and human endogenous retrovirus-w in childhood acute leukemia cells.
    Januszkiewicz-Lewandowska D; Nowicka K; Rembowska J; Fichna M; Żurawek M; Derwich K; Nowak J
    Acta Haematol; 2013; 129(4):232-7. PubMed ID: 23328642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression analysis of human endogenous retrovirus-K Env, Np9, and Rec transcripts in cervical cancer.
    Soleimani-Jelodar R; Arashkia A; Shoja Z; Akhavan S; Yarandi F; Sharifian K; Farahmand M; Nili F; Jalilvand S
    J Med Virol; 2024 Mar; 96(3):e29501. PubMed ID: 38445563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P.
    Huang B; Fu SJ; Fan WZ; Wang ZH; Chen ZB; Guo SJ; Chen JX; Qiu SP
    Cancer Lett; 2016 Jun; 376(1):148-54. PubMed ID: 27037060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of human endogenous retrovirus K transcripts in primary human melanocytes and melanoma cell lines after UV irradiation.
    Reiche J; Pauli G; Ellerbrok H
    Melanoma Res; 2010 Oct; 20(5):435-40. PubMed ID: 20539243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
    Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
    Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.
    Gerby B; Veiga DF; Krosl J; Nourreddine S; Ouellette J; Haman A; Lavoie G; Fares I; Tremblay M; Litalien V; Ottoni E; Kosic M; Geoffrion D; Ryan J; Maddox PS; Chagraoui J; Marinier A; Hébert J; Sauvageau G; Kwok BH; Roux PP; Hoang T
    J Clin Invest; 2016 Dec; 126(12):4569-4584. PubMed ID: 27797342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia.
    Zebisch A; Staber PB; Delavar A; Bodner C; Hiden K; Fischereder K; Janakiraman M; Linkesch W; Auner HW; Emberger W; Windpassinger C; Schimek MG; Hoefler G; Troppmair J; Sill H
    Cancer Res; 2006 Apr; 66(7):3401-8. PubMed ID: 16585161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts.
    Tazzari PL; Cappellini A; Ricci F; Evangelisti C; Papa V; Grafone T; Martinelli G; Conte R; Cocco L; McCubrey JA; Martelli AM
    Leukemia; 2007 Mar; 21(3):427-38. PubMed ID: 17215852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sonic hedgehog maintains survival and growth of chronic myeloid leukemia progenitor cells through β-catenin signaling.
    Su W; Meng F; Huang L; Zheng M; Liu W; Sun H
    Exp Hematol; 2012 May; 40(5):418-27. PubMed ID: 22240607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells.
    Zhou F; Li M; Wei Y; Lin K; Lu Y; Shen J; Johanning GL; Wang-Johanning F
    Oncotarget; 2016 Dec; 7(51):84093-84117. PubMed ID: 27557521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathway.
    Yang P; Dong F; Zhou Q
    Toxicol Lett; 2017 Aug; 278():9-17. PubMed ID: 28666825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
    Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
    Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
    Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
    Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.